Information Library

Results for: Case Studies - Europe

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Energizing Enrollment

    October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Constant Vigilance

    March 16, 2011
    Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met.

  • Scientific Bulletin Flow Cytometry

    February 9, 2011
    Quintiles has expertise in running highly regulated flow cytometry assays, as well as a number of esoteric assays, such as multicolor cell surface and intracellular staining assays, and receptor occupancy/competitive binding assays.

  • Competitive Edge - Ulcerative Colitis

    February 2, 2011
    Although faced with the challenge of recruiting for this small patient population, enrollment was completed two months ahead of schedule.

  • Superior Teamwork - Renal Transplants

    February 2, 2011
    901 patients were randomized according to the protocol timelines. The database lock was achieved 11 days before the original target date.

  • Bypassing Barriers - Refractory Partial Epilepsy

    February 2, 2011
    Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule.

  • Diabetes - Therapeutic Focus

    February 1, 2011
    A dose-ranging clinical study to evaluate the safety, efficacy and tolerability of five doses of Drug X compared with placebo in Type II diabetes patients with no prior exposure to anti-diabetic medication.

  • Parkinson's Disease - Ambitious Recruitment

    February 1, 2011
    Quintiles provided project management, clinical monitoring, and more for a study of a drug for patients with early stage idiopathic Parkinson’s disease.

  • Epilepsy - Refining Recruitment

    February 1, 2011
    Quintiles provided clinical monitoring and project management for a randomized, double-blind, parallel-group, placebo and comparator controlled multicenter study of Drug X in patients with epilepsy.

  • Global Response HIV

    February 1, 2011
    Due to its global reach and extensive experience, Quintiles successfully managed 830 sites in 32 countries and recruited 14,521 patients.

Page 1 of 3 (25 results)

Subscribe to Email Based on Your Interests

Set preferences